MHRA approves first-in-class breast cancer drug 17 Jul 2024 The Institute of Cancer Research, London, welcomes the news that a new targeted breast cancer drug, capivasertib, has been approved by the Medicines & Healthcare products Regulatory Agency (MHRA) for treating the most common type of advanced breast cancer. Find out more Show/Hide
ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team 06 Mar 2024 A global, interdisciplinary team of researchers has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the challenge of solid tumours in children. Find out more Show/Hide
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace 22 Feb 2024 Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme. Find out more Show/Hide
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration 04 May 2023
Researchers discover potential new series of cancer drugs targeting cancer-driving protein BCL6 09 Feb 2023